{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T05:59:37Z","timestamp":1790143177064,"version":"4.0.1"},"reference-count":39,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"National Key Project of Scientific and Technical Supporting Programs Funded by Ministry of Science & Technology of China","award":["2007BAI17B04"],"award-info":[{"award-number":["2007BAI17B04"]}]}],"content-domain":{"domain":["psy-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatry Research"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.psychres.2013.08.056","type":"journal-article","created":{"date-parts":[[2013,10,7]],"date-time":"2013-10-07T08:15:27Z","timestamp":1381133727000},"page":"825-829","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":61,"title":["Relationship between insulin resistance, dyslipidaemia and positive symptom in Chinese antipsychotic-naive first-episode patients with schizophrenia"],"prefix":"10.1016","volume":"210","author":[{"given":"Song","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Broqueres-You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guigang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiren","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanli","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fude","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunlong","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.psychres.2013.08.056_bib1","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.4088\/JCP.v65n1007","article-title":"Insulin resistance and increased leptin concentrations in noncompliant schizophrenia patients but not in antipsychotic-naive first-episode schizophrenia patients","volume":"65","author":"Arranz","year":"2004","journal-title":"The Journal of Clinical Psychiatry"},{"key":"10.1016\/j.psychres.2013.08.056_bib2","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1001\/archinte.164.9.934","article-title":"Women and heart disease: the role of diabetes and hyperglycemia","volume":"164","author":"Barrett-Connor","year":"2004","journal-title":"Archives of Internal Medicine"},{"key":"10.1016\/j.psychres.2013.08.056_bib3","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.cmet.2011.08.005","article-title":"Estrogen receptors and the metabolic network","volume":"14","author":"Barros","year":"2011","journal-title":"Cell Metabolism"},{"key":"10.1016\/j.psychres.2013.08.056_bib4","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.molmed.2006.07.004","article-title":"Estrogen receptors: new players in diabetes mellitus","volume":"12","author":"Barros","year":"2006","journal-title":"Trends in Molecular Medicine"},{"key":"10.1016\/j.psychres.2013.08.056_bib5","first-page":"318","article-title":"Drug Insight: the role of leptin in human physiology and pathophysiology--emerging clinical applications. Nature Clinical Practice","volume":"2","author":"Brennan","year":"2006","journal-title":"Endocrinology & Metabolism"},{"key":"10.1016\/j.psychres.2013.08.056_bib6","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1192\/bjp.171.6.502","article-title":"Excess mortality of schizophrenia. A meta-analysis","volume":"171","author":"Brown","year":"1997","journal-title":"The British Journal of Psychiatry: the Journal of Mental Science"},{"key":"10.1016\/j.psychres.2013.08.056_bib7","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s00213-009-1665-6","article-title":"Decreased levels of serum brain-derived neurotrophic factor in drug-naive first-episode schizophrenia: relationship to clinical phenotypes","volume":"207","author":"Chen da","year":"2009","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.psychres.2013.08.056_bib8","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.psychres.2010.07.054","article-title":"Gender differences in the prevalence of diabetes mellitus in chronic hospitalized patients with schizophrenia on long-term antipsychotics","volume":"186","author":"Chen da","year":"2011","journal-title":"Psychiatry Research"},{"key":"10.1016\/j.psychres.2013.08.056_bib9","doi-asserted-by":"crossref","first-page":"575","DOI":"10.4088\/JCP.v67n0408","article-title":"Metabolic syndrome and the risk of coronary heart disease in 367 patients treated with second-generation antipsychotic drugs","volume":"67","author":"Correll","year":"2006","journal-title":"The Journal of Clinical Psychiatry"},{"key":"10.1016\/j.psychres.2013.08.056_bib10","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1176\/ajp.149.8.1033","article-title":"Hypothalamic-pituitary-adrenal axis hyperactivity and psychosis: recovery during an 8-year follow-up","volume":"149","author":"Coryell","year":"1992","journal-title":"The American Journal of Psychiatry"},{"key":"10.1016\/j.psychres.2013.08.056_bib11","doi-asserted-by":"crossref","first-page":"715","DOI":"10.4088\/JCP.v65n0519","article-title":"Cardiovascular disease in patients with schizophrenia in Saskatchewan, Canada","volume":"65","author":"Curkendall","year":"2004","journal-title":"The Journal of Clinical Psychiatry"},{"key":"10.1016\/j.psychres.2013.08.056_bib12","doi-asserted-by":"crossref","first-page":"4772","DOI":"10.1073\/pnas.94.9.4772","article-title":"Insulin-like growth factor I protects and rescues hippocampal neurons against beta-amyloid- and human amylin-induced toxicity","volume":"94","author":"Dore","year":"1997","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.psychres.2013.08.056_bib13","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1038\/nm.3009","article-title":"Targeted estrogen delivery reverses the metabolic syndrome","volume":"18","author":"Finan","year":"2012","journal-title":"Nature Medicine"},{"key":"10.1016\/j.psychres.2013.08.056_bib14","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1001\/jama.287.3.356","article-title":"Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey","volume":"287","author":"Ford","year":"2002","journal-title":"JAMA: The Journal of the American Medical Association"},{"key":"10.1016\/j.psychres.2013.08.056_bib15","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1210\/en.2009-0996","article-title":"Disruption of the dopamine d2 receptor impairs insulin secretion and causes glucose intolerance","volume":"151","author":"Garcia-Tornadu","year":"2010","journal-title":"Endocrinology"},{"key":"10.1016\/j.psychres.2013.08.056_bib16","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1017\/S0033291700048005","article-title":"A record-linkage study of mortality and general hospital discharge in patients diagnosed as schizophrenic","volume":"13","author":"Herrman","year":"1983","journal-title":"Psychological Medicine"},{"key":"10.1016\/j.psychres.2013.08.056_bib17","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1192\/S0007125000291514","article-title":"The Positive and Negative Syndrome Scale (PANSS): rationale and standardisation","author":"Kay","year":"1989","journal-title":"The British Journal of Psychiatry"},{"key":"10.1016\/j.psychres.2013.08.056_bib18","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.schres.2008.09.023","article-title":"Differences in glucose tolerance between deficit and nondeficit schizophrenia","volume":"107","author":"Kirkpatrick","year":"2009","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.psychres.2013.08.056_bib19","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s00125-006-0537-4","article-title":"Brain-derived neurotrophic factor (BDNF) and type 2 diabetes","volume":"50","author":"Krabbe","year":"2007","journal-title":"Diabetologia"},{"key":"10.1016\/j.psychres.2013.08.056_bib20","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1001\/jama.288.21.2709","article-title":"The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men","volume":"288","author":"Lakka","year":"2002","journal-title":"JAMA: The Journal of the American Medical Association"},{"key":"10.1016\/j.psychres.2013.08.056_bib21","first-page":"803","article-title":"Combined dexamethasone\/corticotropin-releasing hormone test in patients with schizophrenia and in normal controls: II","volume":"38","author":"Lammers","year":"1995"},{"issue":"Suppl 23","key":"10.1016\/j.psychres.2013.08.056_bib22","first-page":"30","article-title":"Hyperglycemia associated with the use of atypical antipsychotics","volume":"62","author":"Lindenmayer","year":"2001","journal-title":"The Journal of Clinical Psychiatry"},{"key":"10.1016\/j.psychres.2013.08.056_bib23","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1192\/bjp.174.2.180b","article-title":"Schizophrenia and diabetes mellitus","volume":"174","author":"Mohan","year":"1999","journal-title":"The British Journal of Psychiatry"},{"key":"10.1016\/j.psychres.2013.08.056_bib24","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/dmrr.290","article-title":"Brain-derived neurotrophic factor (BDNF) regulates glucose and energy metabolism in diabetic mice","volume":"18","author":"Nakagawa","year":"2002","journal-title":"Diabetes\/Metabolism Research and Reviews"},{"issue":"Suppl 1","key":"10.1016\/j.psychres.2013.08.056_bib25","first-page":"1","article-title":"Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review","volume":"19","author":"Newcomer","year":"2005","journal-title":"CNS Drugs"},{"key":"10.1016\/j.psychres.2013.08.056_bib26","doi-asserted-by":"crossref","first-page":"487","DOI":"10.4088\/JCP.08m04132","article-title":"A 24-week, multicenter, open-label, randomized study to compare changes in glucose metabolism in patients with schizophrenia receiving treatment with olanzapine, quetiapine, or risperidone","volume":"70","author":"Newcomer","year":"2009","journal-title":"The Journal of Clinical Psychiatry"},{"key":"10.1016\/j.psychres.2013.08.056_bib27","doi-asserted-by":"crossref","first-page":"36824","DOI":"10.1074\/jbc.M505560200","article-title":"Dopamine D2-like receptors are expressed in pancreatic beta cells and mediate inhibition of insulin secretion","volume":"280","author":"Rubi","year":"2005","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/j.psychres.2013.08.056_bib28","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1176\/appi.ajp.160.2.284","article-title":"Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia","volume":"160","author":"Ryan","year":"2003","journal-title":"The American Journal of Psychiatry"},{"key":"10.1016\/j.psychres.2013.08.056_bib29","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0024-3205(02)01646-6","article-title":"Physical consequences of schizophrenia and its treatment: the metabolic syndrome","volume":"71","author":"Ryan","year":"2002","journal-title":"Life Sciences"},{"key":"10.1016\/j.psychres.2013.08.056_bib30","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.schres.2008.02.013","article-title":"Are metabolic indices different between drug-naive first-episode psychosis patients and healthy controls?","volume":"102","author":"Sengupta","year":"2008","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.psychres.2013.08.056_bib31","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1080\/15216540600687993","article-title":"Dopaminergic regulation of glucose-induced insulin secretion through dopamine D2 receptors in the pancreatic islets in vitro","volume":"58","author":"Shankar","year":"2006","journal-title":"IUBMB Life"},{"key":"10.1016\/j.psychres.2013.08.056_bib32","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.physbeh.2009.02.017","article-title":"Sex differences in the regulation of body weight","volume":"97","author":"Shi","year":"2009","journal-title":"Physiology and Behavior"},{"key":"10.1016\/j.psychres.2013.08.056_bib33","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0140-6736(09)60995-8","article-title":"Schizophrenia","volume":"374","author":"van Os","year":"2009","journal-title":"The Lancet"},{"key":"10.1016\/j.psychres.2013.08.056_bib34","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1176\/appi.ajp.2007.07020233","article-title":"Insulin and insulin-like growth factor-1 abnormalities in antipsychotic-naive schizophrenia","volume":"164","author":"Venkatasubramanian","year":"2007","journal-title":"The American Journal of Psychiatry"},{"key":"10.1016\/j.psychres.2013.08.056_bib35","doi-asserted-by":"crossref","first-page":"997","DOI":"10.4088\/JCP.08m04508","article-title":"Metabolic risk factors in drug-naive patients with first-episode psychosis","volume":"70","author":"Verma","year":"2009","journal-title":"The Journal of Clinical Psychiatry"},{"key":"10.1016\/j.psychres.2013.08.056_bib36","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1159\/000122267","article-title":"Increased plasma leptin in antipsychotic-naive females with schizophrenia, but not in males","volume":"56","author":"Wang","year":"2007","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.psychres.2013.08.056_bib37","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2220\/biomedres.29.147","article-title":"Brain-derived neurotrophic factor (BDNF) prevents the development of diabetes in prediabetic mice","volume":"29","author":"Yamanaka","year":"2008","journal-title":"Biomedical Research"},{"key":"10.1016\/j.psychres.2013.08.056_bib38","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1463-1326.2006.00572.x","article-title":"Brain-derived neurotrophic factor enhances glucose utilization in peripheral tissues of diabetic mice","volume":"9","author":"Yamanaka","year":"2007","journal-title":"Diabetes, Obesity and Metabolism"},{"key":"10.1016\/j.psychres.2013.08.056_bib39","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1038\/sj.npp.1300756","article-title":"Cortisol and cytokines in chronic and treatment-resistant patients with schizophrenia: association with psychopathology and response to antipsychotics","volume":"30","author":"Zhang","year":"2005","journal-title":"Neuropsychopharmacology"}],"container-title":["Psychiatry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178113005179?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178113005179?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,29]],"date-time":"2019-07-29T18:51:22Z","timestamp":1564426282000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165178113005179"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S0165178113005179"],"URL":"https:\/\/doi.org\/10.1016\/j.psychres.2013.08.056","relation":{},"ISSN":["0165-1781"],"issn-type":[{"value":"0165-1781","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Relationship between insulin resistance, dyslipidaemia and positive symptom in Chinese antipsychotic-naive first-episode patients with schizophrenia","name":"articletitle","label":"Article Title"},{"value":"Psychiatry Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psychres.2013.08.056","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}